Intra-Cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/11/2026

1. SKHY
2. USO
3. SPY
4. DAL
5. PEP
6. META
7. SKHYV
8. ALP
9. NVDA
10. NRIX

Go back to Intra-Cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 15c, Revenues Miss

May 10, 2021 7:35 AM EDT

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.65), $0.15 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $16.5 million.

The acceptance of our sNDAs by the FDA is an important step towards a potential... More